OnCo
technologiesTechnologyStandard of care

Low-dose CT lung screening

A yearly low-radiation CT scan for current and former heavy smokers that finds lung cancer early enough to cure it.

Proven by NLST (20% mortality reduction) and NELSON (24% in men). US eligibility: age 50-80, ≥20 pack-years, quit <15 years. Uptake remains under 20% in the US and lower elsewhere; risk models (PLCOm2012), AI nodule scoring (Sybil, Optellum), and blood biomarkers aim to widen and sharpen eligibility. Lung-RADS standardises reporting; volumetric management (NELSON) reduces false positives.

Schematic · not to scale
Rotating X-ray tube · Lung nodule

How it works

Non-contrast helical CT at ~1-1.5 mSv; nodules classified by size, volume, growth, and morphology; AI assists detection and malignancy scoring.

Strengths
  • Only proven mortality-reducing intervention for lung cancer detection
  • Also detects emphysema and coronary calcium
Limitations
  • Low uptake
  • False positives and incidental findings
  • Misses never-smoker adenocarcinomas (rising in East Asia, where risk-based screening is debated)
Since
2011

Key papers

2top

Latest papers

top
Literature trend0 papers in the last 12 monthsHow this is computed
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"Low-dose CT lung screening" OR ABSTRACT:"Low-dose CT lung screening") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Low-dose CT lung screening, not a curated reading list.

Connected

19top

Pages like this

not linked directly; found by shared links